文稿:平民
翻译:Darren
编辑:Tiffany
7月28日11点，一家移动弹出式检测诊所今天揭幕在哈密顿举行。 计划到2030年消除丙型肝炎作为主要的健康威胁，新西兰卫生部副部长Ayesa Verrall博士7月28日今天宣布了一项在新西兰消除丙型肝炎、减少肝癌和肝脏移植需要的计划。 Ayesa Verrall说:”大约45，000名新西兰人得了丙型肝炎，但只有大约一半的人知道他们得了丙型肝炎。症状通常不会出现，直到大部分损害已经造成。如果不治疗，大多数人会发展成渐进性肝损伤。丙型肝炎是新西兰肝移植的主要原因，也是肝癌的第二大病因，仅次于乙型肝炎。同时，许多丙型肝炎患者来自我们最边缘化的社区，在接受检测和治疗方面面临重大障碍，包括病毒的污名化。但是丙型肝炎是可以预防和治愈的″Ayesa Verrall说。 国家丙型肝炎行动计划在汉密尔顿的一家移动弹出式检测诊所揭幕，以纪念世界肝炎日。这是新西兰对世界卫生组织全球肝炎战略的回应，并阐述了到2030年青奥罗亚如何消除丙型肝炎作为主要公共卫生威胁。 自2019年2月以来，约有4，500名新西兰丙型肝炎患者接受了由 PHARMAC 资助的新型直接作用抗病毒治疗 Maviret 的治疗。马维雷特是简单的管理，有较少的副作用比以前的治疗，并有可能治愈98%的慢性丙型肝炎患者。 “马维特确实改变了治疗规则，但单靠资助药物并不能实现去旧创新。我们需要确保找到所有有风险或丙型肝炎的人，给他们做一次检查，并治疗他们”部长说。 根据《行动计划》，工作已经开始，重点是主要举措，包括：· 开展全国提高认识运动· 扩大向注射毒品者免费注射设备的分发，重点预防丙型肝炎和减少新感染。· 通过社区和流动诊所提供更多的护士领导的诊所和护理测试点，增加获得检测的机会。· 增加对检测和治疗的接受。· 开发监控系统和虚拟注册表，将诊断病例与他们需要的治疗联系起来。 “《行动计划》是来自整个卫生系统的一组专家进行重大合作努力的高潮。至关重要的是，这包括非政府组织、一线工作者和社区代表，他们对于如何最好地接触丙型肝炎患者有着宝贵的见解”Ayesha Verrall说。· 丙型肝炎是一种血液传播的病毒，可以通过多种方式传播，包括注射毒品时：在高风险地区接受治疗;和纹身或身体穿孔与设备，尚未消毒。· 世卫组织将消除定义为将慢性丙型肝炎新发病例减少90，将丙型肝炎相关死亡人数减少65（从2015年基准）。· 卫生部已拨款220万纽币，用于资助根据《行动计划》开展活动。此外，每年还为在DHB地区提供的丙型肝炎评估和治疗服务以及针头交换方案提供约700万纽币的持续资金。
At 11 o’clock on July 28, a mobile pop-up testing clinic was opened today in Hamilton.Plan to eliminate hepatitis C as a major health threat by 2030A plan to eliminate hepatitis C in New Zealand, reducing liver cancer and the need for liver transplants, has been released today by Associate Minister of Health Dr Ayesha Verrall.“Around 45,000 New Zealanders have hepatitis C, but only around half know they have it,” said Ayesha Verrall.“Symptoms often don’t appear until much of the damage has been done. Without treatment, most people will develop progressive liver damage. Hepatitis C is the leading cause of liver transplants in New Zealand, and the second leading cause of liver cancer – behind hepatitis B.“At the same time, many of those with hepatitis C are from our most marginalised communities, and face significant barriers to getting tested and treated – including stigma around the virus.“But hepatitis C is preventable, and curable,” said Ayesha Verrall.The National Hepatitis C Action Plan was unveiled at a mobile, pop-up testing clinic in Hamilton, to mark World Hepatitis Day. It’s New Zealand’s response to the World Health Organization’s global hepatitis strategy, and sets out how Aotearoa will eliminate hepatitis C as a major public health threat by 2030.Since February 2019, around 4,500 New Zealanders with hepatitis C have been treated with Maviret, a new direct-acting antiviral treatment funded by PHARMAC. Maviret is simple to administer, has fewer side effects than previous treatments, and can potentially cure 98 percent of people with chronic hepatitis C.“Maviret has been a real game-changer, but funding drugs alone won’t achieve elimination. We need to make sure we find everyone who is at risk or has hepatitis C, offer them a test and to treat them,” said Ayesha Verrall.Work has already begun under the Action Plan, with a focus on key initiatives including:· Developing a national awareness campaign· Upscaling the distribution of free injecting equipment to people who inject drugs, to focus on hepatitis C prevention and reducing new infections· Increasing access to testing through more nurse-led clinics and point of care testing delivered in the community, and through mobile clinics· Increasing uptake of testing and treatment· Developing a surveillance system and virtual registry that will connect diagnosed cases with the treatment they need“The Action Plan is the culmination of a major collaborative effort by a group of experts from across the health system. Crucially, this has included NGOs, frontline workers and community representatives with valuable insights into how best to reach those living with hepatitis C,” said Ayesha Verrall.· Hepatitis C is a blood-borne virus, which can be transmitted through a number of ways, including when injecting drugs; receiving medical treatment in a high-risk region; and tattooing or body piercing with equipment that has not been sterilised· WHO defines elimination as reducing the number of new cases of chronic hepatitis C by 90 percent, and reducing the number of hepatitis C-related deaths by 65 percent (from a 2015 baseline)· The Ministry of Health has allocated $2.2 million towards the funding of initiation of activities under the Action Plan. This is in addition to around $7 million per year in ongoing funding for the hepatitis.
备注和负责声明
未经书面许可，保留所有权利，不得使用任何部分或完整的文章或照片。本号转载的文章都已注明出处，如对版权有任何疑问，请在第一时间发送邮件给本号， bbcc1223@126.com我们将在收到后第一时间进行删除。
若喜欢作品的可以点击“在看”，这样有机会分享给更多朋友。要是再点击“喜欢作品”，那将对我们鼓舞更大。
本号致力于好文推送，并对文中观点保持中立，所发内容仅供学习、交流。版权归原作者或机构所有，部分文章推送时未能查实原作者，在这里对你们表示深深的敬意。若涉及版权问题，麻烦请留言联系删除